Gradient Investments LLC Dexcom Inc Transaction History

Gradient Investments LLC

$4.41 Billion
Q2 2025

A detailed history of Gradient Investments LLC transactions in Dexcom Inc stock. As of the latest transaction made, Gradient Investments LLC holds 269,748 shares of DXCM stock, worth $21.6 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

269,748

Previous 281,325 4.12%

Holding current value

$21.6 Million

Previous $19.2 Million 22.57%

% of portfolio

0.53%

Previous 0.48%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 08, 2025	SELL	$59.83 - $87.57 $692,651 - $1.01 Million	-11,577 Reduced 4.12%	269,748 $23.5 Million
Q1 2025 Apr 09, 2025	BUY	$67.74 - $90.75 $1.81 Million - $2.43 Million	26,782 Added 10.52%	281,325 $19.2 Million
Q4 2024 Jan 21, 2025	BUY	$65.68 - $81.01 $3.87 Million - $4.78 Million	58,947 Added 30.14%	254,543 $19.8 Million
Q3 2024 Oct 15, 2024	BUY	$64.0 - $116.06 $1.77 Million - $3.21 Million	27,657 Added 16.47%	195,596 $13.1 Million
Q2 2024 Jul 18, 2024	BUY	$110.31 - $140.45 $893,290 - $1.14 Million	8,098 Added 5.07%	167,939 $19 Million
Q1 2024 Apr 23, 2024	BUY	$114.22 - $140.1 $799,768 - $980,980	7,002 Added 4.58%	159,841 $22.2 Million
Q4 2023 Jan 18, 2024	BUY	$75.49 - $124.16 $2.55 Million - $4.19 Million	33,742 Added 28.33%	152,839 $19 Million
Q3 2023 Oct 27, 2023	BUY	$86.06 - $137.93 $911,891 - $1.46 Million	10,596 Added 9.77%	119,097 $11.1 Million
Q2 2023 Jul 11, 2023	BUY	$112.47 - $130.98 $685,054 - $797,799	6,091 Added 5.95%	108,501 $13.9 Million
Q1 2023 Apr 17, 2023	BUY	$104.0 - $122.92 $1.41 Million - $1.67 Million	13,584 Added 15.29%	102,410 $11.9 Million
Q4 2022 Jan 10, 2023	SELL	$84.98 - $122.67 $1.23 Million - $1.78 Million	-14,485 Reduced 14.02%	88,826 $0
Q3 2022 Oct 14, 2022	SELL	$76.35 - $94.18 $2.15 Million - $2.65 Million	-28,137 Reduced 21.41%	103,311 $8.32 Million
Q2 2022 Jul 11, 2022	BUY	$67.99 - $132.89 $6.86 Million - $13.4 Million	100,834 Added 329.37%	131,448 $9.8 Million
Q1 2022 May 26, 2022	BUY	$94.08 - $130.2 $389,773 - $539,418	4,143 Added 15.65%	30,614 $15.7 Million
Q4 2021 Jan 12, 2022	BUY	$129.87 - $162.82 $562,856 - $705,661	4,334 Added 19.58%	26,471 $14.2 Million
Q3 2021 Oct 18, 2021	SELL	$106.71 - $143.18 $76,404 - $102,516	-716 Reduced 3.13%	22,137 $12.1 Million
Q2 2021 Jul 12, 2021	BUY	$80.99 - $107.93 $189,030 - $251,908	2,334 Added 11.37%	22,853 $9.76 Million
Q1 2021 Apr 21, 2021	BUY	$84.79 - $104.74 $1.73 Million - $2.13 Million	20,352 Added 12186.83%	20,519 $7.37 Million
Q2 2019 Jul 16, 2019	BUY	$27.84 - $38.92 $4,649 - $6,499	167 New	167 $25,000

Others Institutions Holding DXCM

# of Institutions

1,099

Shares Held

370M

Call Options Held

5.66M

Put Options Held

4.57M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gradient Investments LLC with notifications on news.

Account

Gradient Investments LLC Dexcom Inc Transaction History